MERRY LYNN TETEF M.D. NPI 1194784785

NPI Information

  • NPI: 1194784785
  • Provider Name: MERRY LYNN TETEF, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 24302 PASEO DE VALENCIA STE 200
    LAGUNA HILLS, CA
    ZIP 92653
  • Phone: (949) 458-8252

Map and Directions

Get Directions

NPI Details

Merry Lynn Tetef, M.D. is a hematology and oncology internal medicine in Laguna Hills, CA. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Merry Lynn Tetef, M.D. NPI is 1194784785. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

24302 PASEO DE VALENCIA STE 200
LAGUNA HILLS, CA
ZIP 92653-115
Phone: (949) 458-8252
Fax: (949) 588-8252

The NPI 1194784785 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg (HCPCS:Q5116)
  • Injection, docetaxel, 1 mg (HCPCS:J9171)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)

The enumeration date for this NPI number is 3/21/2006 and was last updated on 5/14/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyG64196CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
11194784785MEDICAIDCALIFORNIA
2FO783ZMEDICARE PINCALIFORNIA
3W10689MEDICARE PINCALIFORNIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.